Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for B^{-}→D^{**0}τ^{-}ν_{τ}[over ¯] Decays.

Physical review letters·2025
Same author

Pollen-induced asthma: a specific pheno-endotype of disease?

European annals of allergy and clinical immunology·2025
Same author

Test of Lepton Flavor Universality with B_{s}^{0}→ϕℓ^{+}ℓ^{-} Decays.

Physical review letters·2025
Same author

Observation of the Open-Charm Tetraquark Candidate T_{cs0}^{*}(2870)^{0} in the B^{-}→D^{-}D^{0}K_{S}^{0} Decay.

Physical review letters·2025
Same author

Study of Λ_{b}^{0} and Ξ_{b}^{0} Decays to Λh^{+}h^{'-} and Evidence for CP Violation in Λ_{b}^{0}→ΛK^{+}K^{-} Decays.

Physical review letters·2025
Same author

First Evidence for Direct CP Violation in Beauty to Charmonium Decays.

Physical review letters·2025

Related Experiment Video

Updated: Jul 16, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Androgen deficiency in older men.

G Valenti1, G Ceresini, M Maggio

  • 1Section of Geriatrics, Department of Internal Medicine and Biomedical Sciences, University of Parma, Via Gramsi 14, 42100 Parma, Italy. giorgiovalenti@libero.it

Minerva Ginecologica
|March 14, 2007
PubMed
Summary

Androgen deficiency in older men impacts somatic, sexual, and psychological health due to neuro-endocrine changes. Treatments include testosterone and dehydroepiandrosterone, with new targeted therapies showing promise.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jul 16, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Endocrinology
  • Geriatrics
  • Men's Health

Background:

  • Aging in men is associated with neuro-endocrine changes affecting testicular and adrenal hormone production.
  • Androgen deficiency can manifest with significant clinical consequences across multiple physiological systems.

Purpose of the Study:

  • To review the clinical consequences of androgen deficiency in older men.
  • To explore current and potential therapeutic interventions for androgen deficiency.

Main Methods:

  • A review of observational studies and randomized placebo-controlled trials from medical literature.
  • Analysis of clinical consequences across somatic, sexual, and psychological domains.

Main Results:

  • Androgen deficiency affects body composition, metabolism, erythropoiesis, sexual function, cognition, and affectivity.
  • Testosterone (transdermal gel) and dehydroepiandrosterone are established treatment options.
  • Novel compounds targeting androgen receptors offer potential anabolic benefits.

Conclusions:

  • Androgen deficiency in aging men has wide-ranging clinical impacts.
  • Hormone replacement therapy, particularly with testosterone, can address these deficiencies.
  • Targeted therapies represent a future direction for managing androgen deficiency and its consequences.